PerkinElmer
check quantity

VivoTag 680XL – MAL Fluorochrome (1 mg)

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
NEV11219
183.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

VivoTag® 680XL – MAL is a thiol (-SH, sulfhydryl) reactive maleimide-containing near infrared (NIR) fluorochrome for molecular labeling applications. VivoTag 680XL-MAL Fluorochrome is optimized and integrated for both in vivo and in vitro applications. VivoTag 680XL-MAL’s superior brightness makes it particularly well suited for the labeling of thiol and cysteine containing molecules for a wide range of imaging applications. VivoTag 680 XL-MAL is available in 1 mg quantitiy. 

Specifications

Fluorescent Agent Type Labeling
Optical Imaging Classification Fluorescence Imaging
Product Brand Name VivoTag
Shipping Condition Blue Ice
Unit Size 1 mg
Wave Length 680 nm
Resources, Events & More
  • All

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.

PDF 4 MB

Flyer

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 748 KB